CRNX - Crinetics Pharmaceuticals, Inc.

📈 Is growth accelerating? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Revenue Growth YoY (%)	2873.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+35818%)	—	—	158.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1880%)	-43.6% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-645%)	—	N/M	-59.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-845%)	-76.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1051%)	—	-24.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-406%)	125.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1463%)	-14.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-280%)	—	—	—	—	—	—	—	—	N/M	N/M	—	-80.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1108%)	-58.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-836%)	-7.8% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-198%)	—	-17.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-312%)	47.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+499%)	-14.4% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-280%)	-21.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-363%)	—	—	—	—	—	—
EPS Growth YoY (%)	-18.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-48.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-43.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-30.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-11.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	1.1% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	5.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-9.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-6.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-29.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-16.0% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	—	-23.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-15.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-32.1% Weak ↑ Weak Improving Year-over-year change in net income	-52.4% Weak ↑ Weak Improving Year-over-year change in net income	-69.3% Weak ↓ Weak Declining Year-over-year change in net income	-56.2% Weak ↓ Weak Declining Year-over-year change in net income	-44.6% Weak ↓ Weak Declining Year-over-year change in net income	-34.1% Weak ↑ Weak Improving Year-over-year change in net income	-33.7% Weak ↑ Weak Improving Year-over-year change in net income	-45.3% Weak ↓ Weak Declining Year-over-year change in net income	-45.5% Weak ↓ Weak Declining Year-over-year change in net income	-33.6% Weak ↓ Weak Declining Year-over-year change in net income	-37.0% Weak ↓ Weak Declining Year-over-year change in net income	-20.3% Weak ↑ Weak Improving Year-over-year change in net income	-32.8% Weak ↑ Weak Improving Year-over-year change in net income	-46.1% Weak ↑ Weak Improving Year-over-year change in net income	-50.5% Weak → Weak Stable Year-over-year change in net income	-62.4% Weak ↓ Weak Declining Year-over-year change in net income	-51.2% Weak → Weak Stable Year-over-year change in net income	-42.3% Weak ↑ Weak Improving Year-over-year change in net income	-52.0% Weak ↓ Weak Declining Year-over-year change in net income	-58.2% Weak ↓ Weak Declining Year-over-year change in net income	-31.9% Weak ↑ Weak Improving Year-over-year change in net income	-48.7% Weak → Weak Stable Year-over-year change in net income	-27.0% Weak ↑ Weak Improving Year-over-year change in net income	-32.7% Weak ↑ Weak Improving Year-over-year change in net income	-92.5% Weak → Weak Stable Year-over-year change in net income	-71.3% Weak ↑ Weak Improving Year-over-year change in net income	-90.2% Weak ↑ Weak Improving Year-over-year change in net income	-123.2% Weak ↑ Weak Improving Year-over-year change in net income	-65.0% Weak ↑ Weak Improving Year-over-year change in net income	-237.0% Weak → Weak Stable Year-over-year change in net income	-218.6% Weak Weak Year-over-year change in net income	-237.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-25.2% Weak Weak Year-over-year change in free cash flow	—	—	-54.4% Weak Weak Year-over-year change in free cash flow	-28.5% Weak Weak Year-over-year change in free cash flow	—	—	—	0.8% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	58.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	—	-32.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	32.9% Excellent Excellent Compound annual revenue growth over 3 years	-51.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	235.4% Excellent Excellent Compound annual revenue growth over 3 years	—	-3.2% Weak Weak Compound annual revenue growth over 3 years	—	104.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	—	—	—	—	38.4% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	11.8% Good ↑ Good Improving Compound annual revenue growth over 5 years	—	-8.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	8.5% Good ↓ Good Declining Compound annual revenue growth over 5 years	43.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	—	-6.5% Weak Weak Compound annual revenue growth over 5 years	-12.0% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-473.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3258%)	-370.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2573%)	-197.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1417%)	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-477.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4079%)	-372.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3202%)	-198.1% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1751%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-435.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-384.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.89x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.03x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Return on Invested Capital (%)	-8.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-12.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	17.8% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	21.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	13.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-10.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-6.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-7.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-18.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-11.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-14.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-14.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-10.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-8.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.0% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	—	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-7.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—
Return on Common Equity (%) (%)	-10.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-12.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-7.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-9.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-161%)	-8.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-7.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-151%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-10.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-20.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-16.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-209%)	-14.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-11.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	-11.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-11.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-9.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-14.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-13.0% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-15.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-202%)	-12.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-8.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-16.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-207%)	-12.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-11.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-8.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-5.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-139%)	-5.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	22.1% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+47%)	27.4% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+82%)	16.8% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+12%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-2501.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1187.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-547.67x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-114.34M	$-101.54M	$-110.90M	$-53.73M	$-94.57M	$-264.55M	$-317.27M	$-302.16M	$-395.92M	$-54.90M	$-142.79M	$-39.55M	$-41.19M	$-32.67M	$-30.91M	$-62.29M	$-145.55M	$-200.69M	$-161.54M	$-178.77M	$-105.58M	$-93.09M	$-117.82M	$-160.81M	$-50.92M	$-40.33M	$-66.58M	$-59.72M	$-62.83M	$-44.97M	$-169.65M	$-68.41M	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Revenue per Share (USD)	$0.10	—	$0.00	$0.01	$0.00	—	$0.00	$0.01	$0.01	—	$0.01	$0.02	$0.05	—	$0.01	$0.01	—	—	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.23	$-1.29	$-1.38	$-1.23	$-1.04	$-0.87	$-0.96	$-0.94	$-0.93	$-0.88	$-1.01	$-0.94	$-0.85	$-0.83	$-0.78	$-0.81	—	$-0.67	$-0.73	$-0.70	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.21	—	$-1.18	$-0.95	$-0.96	—	—	$-0.62	$-0.75	—	$-0.79	—	$-0.76	—	—	—	—	—	$-0.67	$-0.54	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$12.16	$10.38	$11.34	$12.45	$13.41	$14.26	$10.30	$10.51	$11.14	—	$16.93	$4.65	$5.19	—	$6.53	$7.19	$6.34	—	$5.05	$5.44	$4.53	—	—	—	$4.41	—	$5.35	$5.87	$6.32	—	$6.97	$-10.74	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$12.16	$10.38	$11.34	$12.45	$13.41	$14.26	$10.30	$10.51	$11.14	—	$16.93	$4.65	$5.19	—	$6.53	$7.19	$6.34	—	$5.05	$5.44	$4.53	—	—	—	$4.41	—	$5.35	$5.87	$6.32	—	$6.97	$-10.74	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	104.10M	—	94.22M	93.79M	93.10M	—	80.09M	79.01M	72.29M	—	56.81M	54.27M	53.91M	—	53.77M	52.52M	—	—	38.31M	37.06M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Working Capital (USD)	$1.25B	$963.27M	$1.05B	$1.15B	$1.23B	$1.32B	$824.02M	—	$865.46M	—	—	$252.20M	$279.08M	—	$353.77M	$390.17M	$307.99M	—	—	—	$147.54M	—	—	—	$106.41M	—	$127.52M	$140.01M	$150.30M	—	$165.53M	$64.31M	—	—	—	—	—	—
Total Equity (USD)	$1.28B	$992.08M	$1.07B	$1.17B	$1.25B	$1.32B	$832.98M	$830.76M	$874.93M	$539.11M	$547.75M	$254.12M	$280.33M	$316.33M	$351.37M	$386.17M	$303.04M	$331.94M	$193.59M	$201.44M	$149.48M	$168.92M	$187.22M	$202.77M	$108.44M	$117.14M	$129.52M	$142.10M	$152.39M	$160.22M	$167.52M	$-25.18M	$-19.98M	$-15.02M	—	—	$-6.20M	$-463.00K

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗	Q4 FY2015 Dec 31, 2015 10-K ↗
Sales/Revenue/Turnover (USD)	$10.73M	$6.16M	$143.00K	$1.03M	$361.00K	$0.00	$0.00	$399.00K	$640.00K	$0.00	$346.00K	$988.00K	$2.68M	—	$458.00K	$439.00K	$3.13M	—	$0.00	—	—	$0.00	$0.00	$0.00	$71.00K	$321.00K	$505.00K	—	$367.00K	$781.00K	$548.00K	$657.00K	$442.00K	$528.00K	$640.00K	$832.00K	—	—
Net Income, GAAP (USD)	$-127.84M	$-122.81M	$-130.09M	$-115.64M	$-96.77M	$-80.59M	$-76.83M	$-74.06M	$-66.93M	$-60.10M	$-57.46M	$-50.98M	$-45.99M	$-44.99M	$-41.92M	$-42.38M	$-34.63M	$-30.79M	$-27.85M	$-26.09M	$-22.90M	$-21.64M	$-18.32M	$-16.49M	$-17.36M	$-14.55M	$-14.43M	$-12.43M	$-9.02M	$-8.49M	$-7.59M	$-5.57M	$-5.46M	$-2.52M	$-2.38M	$-1.65M	—	—
Operating Cash Flow (USD)	$-124.70M	$-92.90M	$-110.72M	$-85.85M	$-88.45M	$-66.87M	—	$-47.64M	$-52.86M	$-40.81M	$-41.34M	—	$-40.72M	$-35.21M	—	—	$-13.54M	$-22.90M	$-25.67M	$-19.95M	$-20.07M	$-15.94M	$-18.00M	$-15.86M	$-12.23M	$-13.45M	—	—	$-6.76M	$-6.01M	—	—	$-3.41M	$-2.51M	$-2.44M	—	—	—

Crinetics Pharmaceuticals, Inc.

Analytical Summary

38-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CRNX with peers